Seminars in Hematology
Volume 45, Supplement 1 , Pages S35-S37, April 2008

A Prospective, Observational, Post-approval Registry of Inhibitor Patients Treated With Multiple or Single Doses of Recombinant Activated Factor VII

  • Hervé Chambost

      Affiliations

    • Corresponding Author InformationAddress correspondence to Hervé Chambost, MD, Service de Pédiatrie et d'Hématologie Pédiatrique, CHU Timone, 385 Boulevard Jean Moulin, 13385 Marseille, CEDEX 05, France.

Pediatric Hematology Department, Hemophilia Care Center, Children's Hospital La Timone and Mediterranean University, Marseille, France.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Hervé Chambost serves on an advisory board in the field of hemophilia care for Novo Nordisk France.

PII: S0037-1963(08)00047-4

doi:10.1053/j.seminhematol.2008.03.007

Seminars in Hematology
Volume 45, Supplement 1 , Pages S35-S37, April 2008

Article Tools